apex pharma ltd.

What apex pharma ltd. does

Apex Pharma Limited is a Bangladesh-based generic pharmaceutical manufacturer headquartered in Dhaka with manufacturing operations in Gazipur. Founded in 2002 as part of the Syed Manzur Elahi Enterprise conglomerate, the company produces 60+ branded generic products spanning multiple therapeutic categories, including anti-ulcerants, antibiotics, and other prescription segments. Its product portfolio includes technically differentiated formulations such as Vinca (Vonoprazan, a Potassium-Competitive Acid Blocker) and Nexe (delivered via MUPS — Multiple Unit Pellet System — modified-release technology). The company sells through a 1,600+ strong field sales force and 23+ domestic distribution centers, serving prescribers, pharmacies, and hospitals in Bangladesh, and exports to 15+ countries through a formal distribution partnership with Ansari Lifecare for Afghanistan and other regional channels.

The company manufactures in a roughly 136,996 square foot WHO-GMP and ISO certified facility with three segregated production blocks: a Cephalosporin block, a Penicillin block, and a General block, plus dedicated utilities and quality control laboratories. This block-level segregation enables multi-therapeutic-area production under one compliance umbrella and supports both domestic and export-grade quality standards. Apex generates revenue through B2B sales of branded generic formulations to distributors, wholesalers, and institutional buyers, monetizing via per-unit pricing across its 60+ brand portfolio. Its commercial model combines a large domestic field force for prescriber-led demand generation with export partnerships for international revenue. In March 2025, following the passing of founder-Chairman Syed Manzur Elahi, leadership transitioned to Syed Nasim Manzur as Chairman and Dilip Kajuri as Managing Director, marking a generational change at the parent enterprise level.

Operationally, Apex invests in HCP engagement channels including a dedicated product learning portal and continuing medical education activities such as the 2025 CME on Antibiotic Awareness. No AI/ML capabilities are disclosed across research, manufacturing, or commercial functions. No financial figures (revenue, growth rate, margin, or profitability) are publicly disclosed in the input data.

Name

apex pharma ltd.

Legal name

Apex Pharma Limited

Website

https://apexpharmabd.com

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Apex Pharma Limited is a Bangladesh-based generic pharmaceutical manufacturer founded in 2002, producing 60+ branded generic products across multiple therapeutic classes from a WHO-GMP certified Gazipur facility, and selling through a 1,600+ field sales force across Bangladesh with exports to 15+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Antibiotic formulations
• Cephalosporin production
• Finished dosage forms

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Products (Domestic): Manufactures and sells generic pharmaceutical products within Bangladesh through their distribution network. Products include antibiotics, anti-ulcerants, antihypertensives, NSAIDs, antihistamines, and other therapeutic categories across 60+ brands.
2. International Exports: Export of pharmaceutical products to 15+ countries across Asia, Africa, the Middle East, and Latin America. Products include cardiovascular, anti-infective, gastrointestinal and specialty medicines. Exports managed through dedicated International Business Division.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Core offering

Apex Pharma manufactures and sells generic pharmaceutical finished dosage forms across multiple therapeutic classes (antibiotics, anti-ulcerants, antihypertensives, NSAIDs, antihistamines, respiratory, vitamins, ophthalmics) under 60+ brands. Products are manufactured at a purpose-built plant in Gazipur with three segregated facilities (General, Cephalosporin, Penicillin) and distributed domestically in Bangladesh and exported to 15+ countries.

Product overview

Apex Pharma Limited is a Bangladeshi pharmaceutical company offering a portfolio of 60+ generic medicine brands across multiple therapeutic categories. The product portfolio includes antibiotics (Cephalosporins, Macrolides, Fluoroquinolones), anti-ulcerants (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers), NSAIDs, antihistamines, antihypertensives, respiratory medications, vitamins, and ophthalmic products. The company operates three separate manufacturing facilities (General, Cephalosporin, and Penicillin) to ensure quality and prevent cross-contamination. Products are distributed domestically in Bangladesh and exported to 15+ countries across Asia, Africa, the Middle East, and Latin America.

Differentiator

Problem solved

Functional benefit

Brands

• Apex Pharma Limited: Pharmaceutical business of Syed Manzur Elahi Enterprise

Products and services

• Angical 50 Fixed-dose combination of Amlodipine Besilate (5 mg) and Atenolol (50 mg) used for hypertension management, angina pectoris, and post-myocardial infarction treatment.
• Apeclo Aceclofenac (100 mg) NSAID with analgesic, anti-inflammatory, and antipyretic properties; also stimulates glycosaminoglycans synthesis for cartilage protection.
• Azinil Azithromycin (250 mg/500 mg tablet and suspension) macrolide antibiotic for respiratory infections, skin infections, typhoid fever, and sexually transmitted diseases.
• Bilaxe Bilastine (20 mg) antihistamine for symptomatic relief of allergic rhinitis, allergic rhino-conjunctivitis, and urticaria.
• Clavutil Cefuroxime + Clavulanic Acid combination antibiotic (250 mg/500 mg tablet and PFS) for respiratory infections, otitis media, urinary tract infections, and Lyme disease.
• Gavipex Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate antacid suspension for gastric reflux, heartburn, and epigastric distress.
• Itrapex Itraconazole (100 mg capsule) triazole antifungal for oropharyngeal candidiasis, vulvovaginal candidiasis, tinea infections, onychomycosis, and systemic fungal infections.
• Mirapex Butamirate Citrate (7.5 mg/5 ml) cough suppressant acting on the brain's cough center for dry (non-productive) cough relief.
• Montelon Montelukast (4 mg/5 mg/10 mg) leukotriene receptor antagonist for asthma prophylaxis, chronic treatment, seasonal allergic rhinitis, and exercise-induced bronchoconstriction.
• Moxigram Moxifloxacin 0.5% ophthalmic solution, a broad-spectrum fluoroquinolone for bacterial conjunctivitis, blepharitis, and blepharo-conjunctivitis.
• Napronex Naproxen Sodium + Esomeprazole combination (375/20 mg and 500/20 mg) NSAID with proton pump inhibitor for osteoarthritis, rheumatoid arthritis, and gastric ulcer risk reduction.
• Nervex Vitamin B1 + B6 + B12 combination supplement for B-vitamin deficiency, diabetic neuropathy, sciatica, peripheral neuralgia, and spinal pain.
• Nexe Esomeprazole (20 mg/40 mg) proton pump inhibitor in tablet, capsule, suspension, and IV injection forms for GERD, erosive esophagitis, and H. pylori eradication.
• Nexe Mups Esomeprazole MUPS (Multiple-Unit Pellet System) tablet (20 mg/40 mg) for GERD, NSAID-associated gastric ulcer prevention, and H. pylori eradication.
• Texit Cefixime (200 mg/400 mg capsule, pediatric drops, PFS) third-generation cephalosporin antibiotic for respiratory infections, otitis media, urinary tract infections, and typhoid fever.
• Vinca Vonoprazan (10 mg) potassium competitive acid blocker (PCAB) for gastric ulcer, duodenal ulcer, reflux esophagitis, and H. pylori eradication.
• Xoricard Olmesartan Medoxomil (20 mg) angiotensin-II receptor antagonist (AT1 subtype) for hypertension treatment.
• Alafree Fexofenadine Hydrochloride (120 mg tablet, 30 mg/5 ml suspension) selective peripheral H1-receptor antagonist for seasonal allergic rhinitis and chronic idiopathic urticaria.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Ansari Lifecare Ltd.coreChannel Partner/ Reseller/ Distributor · 1 January 2000Strategic partnership between Apex Pharma Bangladesh and Ansari Lifecare Ltd. Afghanistan for enhancing healthcare solutions and improving access to essential medicines in Afghanistan. Apex Pharma manufactures essential and life-saving medicines including antibiotics, cardiovascular drugs, anti-ulcerants, anti-asthmatic medications and pain relievers. Ansari Lifecare distributes these medicines across Afghanistan using their robust distribution network to reach remote and underserved areas. Both companies committed to maintaining highest standards of quality and compliance.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Square Pharmaceuticals Limited: Largest pharmaceutical company in Bangladesh, manufacturing generic medicines across therapeutic categories with WHO-GMP certified facilities and significant export operations. Most directly comparable peer to Apex Pharma in terms of product breadth, therapeutic categories, and export footprint.
• Beximco Pharmaceuticals Limited: Leading Bangladeshi generic pharmaceutical manufacturer with WHO-GMP certified facilities exporting to 50+ countries. Operates across similar therapeutic categories (antibiotics, cardiovascular, anti-ulcerants) and serves as a benchmark for export-oriented Bangladeshi generics.
• Renata Limited (formerly Beximco Infusions): Diversified Bangladeshi pharmaceutical company producing human and animal health products including antibiotics, hormones, and specialty formulations. Comparable to Apex in domestic market positioning and export ambitions.
• Incepta Pharmaceuticals Limited: Bangladesh's second-largest pharmaceutical company by domestic sales, manufacturing generics and exporting to 100+ countries. Similar in scale, manufacturing footprint, and focus on affordable generics to Apex.
• Eskayef Pharmaceuticals Limited: Bangladeshi generic manufacturer with WHO-GMP, EU GMP certified facilities and exports to 30+ countries. Comparable therapeutic breadth and export-oriented business model.
• ACI Limited (Pharma Division): Bangladeshi conglomerate with a substantial pharmaceutical division manufacturing branded generics across multiple therapeutic categories. Comparable in therapeutic breadth and domestic distribution model.
• Healthcare Pharmaceuticals Limited: Bangladeshi pharmaceutical manufacturer with WHO-GMP certified facilities producing generics across antibiotics, cardiovascular, and other therapeutic areas. Comparable in scale and product portfolio to Apex.

Broad incumbents

• Sun Pharmaceutical Industries Limited: India's largest pharmaceutical company and a global generic manufacturer with diversified portfolio across specialty, branded generics, and APIs. Comparable as a large-scale generic manufacturer targeting emerging markets, though significantly larger and more globally diversified.
• Cipla Limited: Indian multinational pharmaceutical company with strong presence in Africa, Asia, and emerging markets. Comparable in focus on affordable generics for respiratory, anti-infective, and cardiovascular categories, and in export-oriented business model.
• Dr. Reddy's Laboratories Limited: Indian integrated pharmaceutical company with global generics operations spanning regulated and emerging markets. Comparable as a manufacturer of affordable generics targeting emerging markets including Asia and Africa.

Market position

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/apex-pharma-limited

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about apex pharma ltd.